Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Nazarenko

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Kardiologiia|November 13, 2019
The Role of MicroRNA in AtherogenesisAksana N Kucher, M S Nazarenko
Kardiologiia|February 22, 2018
[The Role of MicroRNA in Atherogenesis]A N Kucher, M S Nazarenko
Biochemistry. Biokhimiia|December 11, 2017
Role of microRNA in Development of Instability of Atherosclerotic PlaquesI A Koroleva, M S Nazarenko, A N Kucher
Genetika|July 1, 2006
[Frequencies of C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene at the early stage of human individual development]M S Nazarenko, V P Puzyrev, I N Lebedev
Molekuliarnaia Biologiia|January 27, 2022
[MicroRNAs as the Potential Regulators of SARS-CoV-2 Infection and Modifiers of the COVID-19 Clinical Features]A N Kucher, Iu A Koroleva, A A Zarubin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 8, 2024
[The association of single-nucleotide polymorphism rs6265 of the brain-derived neurotrophic factor gene with clinical features in Parkinson's disease]M A Nikitina, E Yu Bragina, M S Nazarenko, et al.
Molekuliarnaia Biologiia|April 11, 2022
[miRNA Regulome in Different Atherosclerosis Phenotypes]M S Nazarenko, I A Koroleva, A A Zarubin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 29, 2022
[The role of alleles with an intermediate number of trinucleotide repeats in Parkinson's disease and other neurodegenerative disorders]M A Nikitina, E Yu Bragina, M S Nazarenko, et al.
Russian Journal of Genetics|July 12, 2021
Genetic Control of Human Infection with SARS-CoV-2A N Kucher, N P Babushkina, A A Sleptcov, et al.
Molecular Biology|April 25, 2022
MicroRNAs as the Potential Regulators of SARS-CoV-2 Infection and Modifiers of the COVID-19 Clinical FeaturesA N Kucher, Iu A Koroleva, A A Zarubin, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Kardiologiia|November 13, 2019
The Role of MicroRNA in AtherogenesisAksana N Kucher, M S Nazarenko
Kardiologiia|February 22, 2018
[The Role of MicroRNA in Atherogenesis]A N Kucher, M S Nazarenko
Biochemistry. Biokhimiia|December 11, 2017
Role of microRNA in Development of Instability of Atherosclerotic PlaquesI A Koroleva, M S Nazarenko, A N Kucher
Genetika|July 1, 2006
[Frequencies of C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene at the early stage of human individual development]M S Nazarenko, V P Puzyrev, I N Lebedev
Molekuliarnaia Biologiia|January 27, 2022
[MicroRNAs as the Potential Regulators of SARS-CoV-2 Infection and Modifiers of the COVID-19 Clinical Features]A N Kucher, Iu A Koroleva, A A Zarubin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 8, 2024
[The association of single-nucleotide polymorphism rs6265 of the brain-derived neurotrophic factor gene with clinical features in Parkinson's disease]M A Nikitina, E Yu Bragina, M S Nazarenko, et al.
Molekuliarnaia Biologiia|April 11, 2022
[miRNA Regulome in Different Atherosclerosis Phenotypes]M S Nazarenko, I A Koroleva, A A Zarubin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 29, 2022
[The role of alleles with an intermediate number of trinucleotide repeats in Parkinson's disease and other neurodegenerative disorders]M A Nikitina, E Yu Bragina, M S Nazarenko, et al.
Russian Journal of Genetics|July 12, 2021
Genetic Control of Human Infection with SARS-CoV-2A N Kucher, N P Babushkina, A A Sleptcov, et al.
Molecular Biology|April 25, 2022
MicroRNAs as the Potential Regulators of SARS-CoV-2 Infection and Modifiers of the COVID-19 Clinical FeaturesA N Kucher, Iu A Koroleva, A A Zarubin, et al.
Pageof 3